Trials / Completed
CompletedNCT00174278
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
Treatment With Recombinant Human Growth Hormone (Genotonorm®) In Children With Short Stature Secondary To A Long Term Corticoid Therapy. A Study of Efficacy and Safety.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 14 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effect of long-term treatment by Genotonorm on linear growth
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatropin |
Timeline
- Start date
- 1997-02-01
- Completion
- 2006-10-01
- First posted
- 2005-09-15
- Last updated
- 2008-08-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00174278. Inclusion in this directory is not an endorsement.